The Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia

Recruiting now · Not applicable

Conditions studied: Coccydynia

In brief

In this prospective, randomized, controlled, double-blinded study, we aimed to evaluate the effects of Dextrose Prolotherapy injections in patients with coccydynia.

Key facts

Study ID

NCT07552298

Run by

Istanbul University

People needed

40

Starts

2025-06-15

Expected to finish

2026-11-15

Last updated by the study team

2026-04-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with coccydynia lasting longer than 6 months,
• Those unresponsive to at least 6 months of conventional conservative treatment methods,
• Those with coccygeal tenderness on palpation,
• Patients aged between 18 and 65 years.

You may not qualify if…

• Patients with a history of trauma within the last 3 months or postpartum coccydynia,
• Those with lesions or infections at the injection site,
• Those with dislocation or organic bone pathology of the coccyx observed on X-ray imaging,
• Those with fecal or urinary incontinence,
• Patients with poorly controlled diabetes mellitus,
• Those with a history of malignancy,
• Patients with a bleeding tendency (acquired or hereditary) [INR > 2 in patients using warfarin],
• Those with a history of myelomeningocele,
• Those diagnosed with spina bifida,
• Patients with rheumatologic disease,
• Those who have undergone coccyx injection or ganglion block within the last 3 months,
• Patients with severe comorbidities.

Where it is running

• Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation — Istanbul, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.